Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Hydroxyurea. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
| ▸ | OGG1 | O15527 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9764870 | 0.76 | ALDH1A1 (0.38) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL9764833 | 0.76 | ALOX5 (0.43) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL19768715 | 0.76 | GPR3 (0.56) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL9764874 | 0.75 | MAPT (0.37) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| Hydroxyurea SCHEMBL10559837 | 0.75 | MAPT (0.42) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL10559630 | 0.74 | ALOX5 (0.42) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL11232390 | 0.72 | AKR1B1 (0.53) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL25721910 | 0.71 | ALDH1A1 (0.50) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL9764912 | 0.71 | ALOX5 (0.47) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL19802864 | 0.71 | ALDH1A1 (0.58) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0422079-A4 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | — | 1991-08-21 | — | — | EP | disclosed |
| EP-0422079-A1 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | ABBOTT LABORATORIES (US) | 1991-04-17 | — | — | EP | disclosed |
| WO-1989012636-A1 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | ABBOTT LABORATORIES (US) | 1989-12-28 | — | — | WO | disclosed |